Fly exclusive: Salarius CEO says COVID-related impact ‘manageable’

Despite the ongoing pandemic, Salarius clinical trials in Ewing sarcoma and advanced solid tumor continue to enroll patients. In an exclusive… To see the rest of the story go to thefly.com. (See Story Here):(https://www.thefly.com/permalinks/entry.php/id3150612/-Fly-exclusive-Salarius-CEO-says-COVIDrelated-impact-manageable)